News

Press Releases

May 13, 2014
Arcturus Therapeutics Announces Allele-Specific Silencing Technology at IBC’s 16th Annual TIDES Conference

May 6, 2014
Arcturus Therapeutics Appoints Robert Baltera and Stuart Collinson, Ph.D. to its Board of Directors

April 7, 2014
Arcturus Therapeutics to Present at the 13th Annual Needham Healthcare Conference

March 27, 2014
Arcturus Therapeutics to Present at the BioCentury Future Leaders in the Biotech Industry Conference

March 10, 2014
Arcturus Therapeutics to Present at the BIO-Europe Spring Partnering Conference

February 24, 2014
Arcturus Therapeutics to Present RNAi Data for Orphan Diseases Utilizing the LUNARTM Technology Platform at BIOCOM’s Global Life Science Partnering Conference

January 30, 2014
Arcturus Therapeutics to Present at the Keystone Symposia Conference on RNA Silencing

January 13, 2014
Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program

January 7, 2014
Arcturus Therapeutics, Inc. to Present at the Biotech Showcase 2014

October 28, 2013
Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer

October 21, 2013
Arcturus Therapeutics Raises $5 Million in Series A Funding to Maintain its Momentum in Nominating Lead Clinical Candidate in 2014

August 14, 2013
Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina

June 3, 2013
Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding

May 8, 2013
Arcturus Therapeutics Announces New Appointments to its Board of Directors and Scientific Advisory Board

March 4, 2013
Arcturus Therapeutics Begins Operations in Janssen Labs

Third Party Press

June 23, 2014
Why San Diego is a Hub for RNA R&D and Drug Development

February 27, 2014
Arcturus Releases Data Showing Potential of Delivery Technology for CRISPR Drugs

January 13, 2014
Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program

October 23, 2013
FierceDrugDelivery: Arcturus rakes in $5M to back RNAi tech, nanoparticle delivery Read more: Arcturus rakes in $5M to back RNAi tech, nanoparticle delivery

October 22, 2013
San Diego’s Arcturus Raises $5M for “Best-in-Class” RNAi Technology

October 22, 2013
Arcturus Raises $5M in Series A Funding

October 21, 2013
GenomeWeb Acturus Closes $5M Series A Round, Aims for Clinic in '15 with RNAi Drug

October 21, 2013
RNAi firm raises $5M to develop and deliver drugs that turn off disease-causing genes Read more: http://medcitynews.com/2013/10/arcturus-therapeutics-series/#ixzz2iN5nIo9c

October 21, 2013
Arcturus Therapeutics Raises $5 Million in Series A

August 16, 2013
San Diego upstart acquires RNA tech from cash-strapped Marina Biotech

August 16, 2013
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More

August 15, 2013
San Diego Business Journal: Arcturus Therapeutics Acquires Patent

August 14, 2013
Dirk Haussecker RNAi Blog: Arcturus Therapeutics Acquires usiRNA Technology from Marina

August 14, 2013
Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech

August 14, 2013
Arcturus Acquires UNA Patent Estate from Marina

June 5, 2013
Fierce Drug Delivery: Janssen Labs based Arcturus gets financing (boost for RNAi delivery tech)

June 4, 2013
Fierce Drug Delivery Arcturus Therapeutics Press

June 4, 2013
Gene Silencing News (GenomeWeb) : Startup Arcturus Pulls in Seed Money amid Renewed Interest in RNAi

June 3, 2013
With $1.3M in Seed Funding, Arcturus Adds to RNAi Hub in San Diego

June 3, 2013
Dirk Haussecker RNAi Blog: New Star Rises on RNA(i) Therapeutics Firmament

June 3, 2013
RNAi therapeutics startup sets up shop at Janssen labs, closes $1.3M seed round

June 3, 2013
Wall Street Journal Arcturus Therapeutics Raises Series Seed Funding

June 3, 2013
New Release: On website

© 2014 Arcturus Therapeutics, Inc.